Collegium pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Collegium Pharmaceutical Inc: Is Infosys Ltd. worth buying?
Item: Collegium Pharmaceutical Inc
Rating: 2.791694375
Author: Trendlyne DVM scores

Mid-range Performer

about

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain...

45.50 -1.60 (-3.40%)

95.87% Gain from 52W Low

254.5K

XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

High Financial Strength

61.1 / 100

Mid Valuation

49.8 / 100

Technically Neutral

51.3 / 100

Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM

1Yr Price target upside is 17%

6 analysts

Collegium pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Collegium pharma Inc Live Stock Price Today, Share Analysis and Chart

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain...

95.87% Gain from 52W Low

SWOT Analysis

Collegium pharma Inc Live Price Chart